Screening value with123I-MIBG, neuronal specific enolase and serum ferritin in the diagnosis and follow-up of patients with neuroblastoma;Valor del rastreo con 123I-MIBG, enolasa neuronal específica y ferritina sérica en el diagnóstico y seguimiento de pacientes con neuroblastoma

Revista Espanola de Medicina Nuclear

Volumn 20, Issue 5, 2001, Pages 369-376

  Hervas Benito I ^a   Rivas Sanchez A ^a   Bello Arques, P ^a   Canete A ^a   Maria Fernandez J ^a   Saura Quiles, A ^a   Gonzalez Cabezas P ^a   Ruiz Rodriguez J C ^a   Castell, V ^a   Perez Pastor J L ^a   Monfort, J A ^a   Mateo Navarro, A ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Ferritin; Neuroblastoma; Neuron specific enolase

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; FERRITIN; NEURON SPECIFIC ENOLASE; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; ENOLASE; RADIOACTIVE IODINE; TUMOR MARKER;

ARTICLE; CANCER DIAGNOSIS; CANCER RELAPSE; CANCER SCINTISCANNING; CANCER SCREENING; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HUMAN; INFANT; MALE; NEUROBLASTOMA; PATHOLOGY; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; STATISTICAL SIGNIFICANCE; STUDENT T TEST; ADRENAL TUMOR; BLOOD; EVALUATION; MEDIASTINUM TUMOR; MORTALITY; MULTIMODALITY CANCER THERAPY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RETROPERITONEAL TUMOR; SCINTISCANNING; TREATMENT OUTCOME;

3-IODOBENZYLGUANIDINE; ADRENAL GLAND NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; FERRITINS; GANGLIONEUROBLASTOMA; HUMANS; INFANT; IODINE RADIOISOTOPES; MALE; MEDIASTINAL NEOPLASMS; NEUROBLASTOMA; PHOSPHOPYRUVATE HYDRATASE; PREDICTIVE VALUE OF TESTS; RETROPERITONEAL NEOPLASMS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 17744409037     PISSN: 02126982     EISSN: 1578200X     Source Type: Journal    
DOI: 10.1016/S0212-6982(01)71976-3     Document Type: Article

References (15)

1. 131-MIBG imaging to monitor chemotherapy response in advanced neuroblastoma: comparison to laboratory analysis. J Nucl Med 1994;35:1429-35.
2. Alexander F. Neuroblastoma. Urol Clin North Am 2000;27:383-92.
3. 131-metaiodobenzylguanidine scintigraphy for localization of lesions in children with neuroblastoma: comparison with computed tomography and ultrasonography. Eur J Nucl med 1993;20:1161-7.
4. 131 MIBG imaging and biological markers in advanced neuroblastoma. Clin Nucl Med 1988;13:46-52.
5. 123I-MIBG scintigraphy and catecholamine metabolites. Nuklearmedicine 1996;35:220-4.
6. 123I-metaiodobenzylguanidine scintigraphy on diagnostics and follow-up of neuroblastoma. Acta Oncol 1995;34:505-10.
7. 131-MIBG imaging after bone marrow transplantation for neuroblastoma. Radiology 1992;182:515-20.
8. Zeltzer PM, Marangos PJ, Parma AM, Sather H, Dalton A, Hammond D, et al. Raised neuron-specific enolase in serum of children with metastatic neuroblastoma. Lancet 1983;46:361-3.
9. Tsuchida Y, Honna T, Iwanaka T, Saeki M, Taguchi N, Kaneko T, et al. Serial determination of serum neuron-specific enolase in patients with neuroblastoma and other paediatric tumours. J Pediatr Surg 1987;22:419-24.
10. Cooper EH, Pritchard J, Bailey CC, Ninane J. Serum neuron-specific enolase in children's cancer. Br J Cancer 1987;56:65-7.
11. Massaron S, Seregni E, Luksch R, Casanova M, Botti C, Ferrari L, et al. Neuron-specific enolase evaluation in patients with neuroblastoma. Tumour Biol 1998;19:261-8.
12. Viallard JL, Tiget F, Hartmann O, Lemerle J, Demeocq F, Malpuech G, et al. Serum neuron-specific/nonneuronal enolase ratio in the diagnosis of neuroblastomas. Cancer 1988;62:2546-53.
13. Hann HW, Stahlhut MW, Evans AE. Serum ferritin as a prognostic indicator in neuroblastoma: biological effects of isoferritins. Prog Clin Biol Res 1985;175:331-45.
14. Berthold F, Hunneman DH, Harms D, Käser H, Zieschang J. Serum vanillylmandelic acid/homovanillic acid contributes to prognosis estimation in patients with localised but not with metastatic neuroblastoma. Eur J Cancer 1992;28:1950-4.
15. Silber JH, Evans AE, Fridman M. Models to predict outcome